Recent advances in the control and function of the anterior pituitary

Larry D. Stonesifer, Peter Kohler

Research output: Contribution to journalArticle

Abstract

Major advances in our understanding of the synthesis and release of anterior pituitary hormones have been made over the past several years. Neurons of the hypothalamus have been found to serve as "neuroendocrine transducers" in that they have both electrical and secretory functions. Peptidergic neurons respond to appropriate stimuli with a release of hypothalamic factors into the hypophyscal-portal system. These factors or hormones ultimately control the endocrine function of anterior pituitary cells. Three hormones, Thyrotropin Releasing Hormone (TRII), Gonadotropin Releasing Hormone (GnRH or LHRH) and somatostatin have been identified, synthesized and tested for clinical applications. The clinical assessment of pituitary function has been greatly improved by new and improved radioimmunoassays. One of the recent clinical advances in the area of pituitary disease has been the determination of the relatively high frequency of prolactinomas. Prolactin secreting microadenomas are an important and treatable cause of amenorrhea and infertility in young women. In addition, many pituitary tumors previously believed to be non-functional or "chromophobe adenomas" appear to be prolactinomas. Many new diagnostic and therapeutic techniques are continuing to be developed to improve our management of patients with hypothalamic-pituitary disease.

Original languageEnglish (US)
Pages (from-to)237-242
Number of pages6
JournalClinical Biochemistry
Volume14
Issue number5
DOIs
StatePublished - 1981
Externally publishedYes

Fingerprint

Gonadotropin-Releasing Hormone
Pituitary Diseases
Prolactinoma
Neurons
Hypothalamic Diseases
Chromophobe Adenoma
Hormones
Anterior Pituitary Hormones
Portal System
Thyrotropin-Releasing Hormone
Amenorrhea
Pituitary Neoplasms
Somatostatin
Transducers
Prolactin
Infertility
Hypothalamus
Radioimmunoassay
Tumors
Therapeutics

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Recent advances in the control and function of the anterior pituitary. / Stonesifer, Larry D.; Kohler, Peter.

In: Clinical Biochemistry, Vol. 14, No. 5, 1981, p. 237-242.

Research output: Contribution to journalArticle

@article{fc0c81f916674357b92aab570abe4fc3,
title = "Recent advances in the control and function of the anterior pituitary",
abstract = "Major advances in our understanding of the synthesis and release of anterior pituitary hormones have been made over the past several years. Neurons of the hypothalamus have been found to serve as {"}neuroendocrine transducers{"} in that they have both electrical and secretory functions. Peptidergic neurons respond to appropriate stimuli with a release of hypothalamic factors into the hypophyscal-portal system. These factors or hormones ultimately control the endocrine function of anterior pituitary cells. Three hormones, Thyrotropin Releasing Hormone (TRII), Gonadotropin Releasing Hormone (GnRH or LHRH) and somatostatin have been identified, synthesized and tested for clinical applications. The clinical assessment of pituitary function has been greatly improved by new and improved radioimmunoassays. One of the recent clinical advances in the area of pituitary disease has been the determination of the relatively high frequency of prolactinomas. Prolactin secreting microadenomas are an important and treatable cause of amenorrhea and infertility in young women. In addition, many pituitary tumors previously believed to be non-functional or {"}chromophobe adenomas{"} appear to be prolactinomas. Many new diagnostic and therapeutic techniques are continuing to be developed to improve our management of patients with hypothalamic-pituitary disease.",
author = "Stonesifer, {Larry D.} and Peter Kohler",
year = "1981",
doi = "10.1016/S0009-9120(81)90952-8",
language = "English (US)",
volume = "14",
pages = "237--242",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Recent advances in the control and function of the anterior pituitary

AU - Stonesifer, Larry D.

AU - Kohler, Peter

PY - 1981

Y1 - 1981

N2 - Major advances in our understanding of the synthesis and release of anterior pituitary hormones have been made over the past several years. Neurons of the hypothalamus have been found to serve as "neuroendocrine transducers" in that they have both electrical and secretory functions. Peptidergic neurons respond to appropriate stimuli with a release of hypothalamic factors into the hypophyscal-portal system. These factors or hormones ultimately control the endocrine function of anterior pituitary cells. Three hormones, Thyrotropin Releasing Hormone (TRII), Gonadotropin Releasing Hormone (GnRH or LHRH) and somatostatin have been identified, synthesized and tested for clinical applications. The clinical assessment of pituitary function has been greatly improved by new and improved radioimmunoassays. One of the recent clinical advances in the area of pituitary disease has been the determination of the relatively high frequency of prolactinomas. Prolactin secreting microadenomas are an important and treatable cause of amenorrhea and infertility in young women. In addition, many pituitary tumors previously believed to be non-functional or "chromophobe adenomas" appear to be prolactinomas. Many new diagnostic and therapeutic techniques are continuing to be developed to improve our management of patients with hypothalamic-pituitary disease.

AB - Major advances in our understanding of the synthesis and release of anterior pituitary hormones have been made over the past several years. Neurons of the hypothalamus have been found to serve as "neuroendocrine transducers" in that they have both electrical and secretory functions. Peptidergic neurons respond to appropriate stimuli with a release of hypothalamic factors into the hypophyscal-portal system. These factors or hormones ultimately control the endocrine function of anterior pituitary cells. Three hormones, Thyrotropin Releasing Hormone (TRII), Gonadotropin Releasing Hormone (GnRH or LHRH) and somatostatin have been identified, synthesized and tested for clinical applications. The clinical assessment of pituitary function has been greatly improved by new and improved radioimmunoassays. One of the recent clinical advances in the area of pituitary disease has been the determination of the relatively high frequency of prolactinomas. Prolactin secreting microadenomas are an important and treatable cause of amenorrhea and infertility in young women. In addition, many pituitary tumors previously believed to be non-functional or "chromophobe adenomas" appear to be prolactinomas. Many new diagnostic and therapeutic techniques are continuing to be developed to improve our management of patients with hypothalamic-pituitary disease.

UR - http://www.scopus.com/inward/record.url?scp=0019806476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019806476&partnerID=8YFLogxK

U2 - 10.1016/S0009-9120(81)90952-8

DO - 10.1016/S0009-9120(81)90952-8

M3 - Article

C2 - 6277529

AN - SCOPUS:0019806476

VL - 14

SP - 237

EP - 242

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 5

ER -